Research & Advocacy
Research, Advocacy & Community
Supporting awareness, participation and a stronger amyloidosis community.
Explore patient-friendly awareness on amyloidosis, symptoms, diagnosis pathways and care.
Practical guidance and trusted information for patients and families affected by amyloidosis.
Bringing patients, caregivers and families together through awareness, understanding and community support.
A focused support ecosystem for patients, caregivers and families seeking reliable guidance, education and community connection around amyloidosis.
People • Knowledge • Support • A Stronger Tomorrow
Amyloidosis refers to a group of rare conditions in which abnormal proteins, known as amyloid, build up in tissues and organs. These deposits may interfere with normal organ function and can affect areas such as the heart, kidneys, liver, nerves and digestive system.
Because the symptoms may resemble those of other medical conditions, recognising possible warning signs and receiving appropriate specialist evaluation can be important in the diagnosis and care journey.
Some studies report amyloidosis in about 8% of kidney biopsy cases.
About half of patients with AL amyloidosis may have heart involvement.
Estimated new cardiac amyloidosis cases emerging in India each year.
Timely recognition may support earlier referral, evaluation and informed medical care.
ASGI supports patients and families with accessible information, awareness and guidance around amyloidosis.
Clear Information • Early Recognition • Better Care
Amyloidosis refers to a group of rare conditions in which abnormal proteins, known as amyloid, build up in tissues and organs. These deposits may interfere with normal organ function and can affect areas such as the heart, kidneys, liver, nerves and digestive system.
Because the symptoms may resemble those of other medical conditions, recognising possible warning signs and receiving appropriate specialist evaluation can be important in the diagnosis and care journey.
Some studies report amyloidosis in about 8% of kidney biopsy cases.
About half of patients with AL amyloidosis may have heart involvement.
Estimated new cardiac amyloidosis cases emerging in India each year.
Timely recognition may support earlier referral, evaluation and informed medical care.
ASGI supports patients and families with accessible information, awareness and guidance around amyloidosis.
Concise PDF-based learning resources designed to support awareness, patient understanding and guided amyloidosis education.
Visionary Founder – ASGI & RDSSDF
In July 2022, Prof. (Dr.) Satish Chandra was diagnosed with AL Amyloidosis Cardiac — a rare, life-threatening condition that changed everything. Rather than retreat, he transformed personal adversity into national purpose.
As the visionary founder of the Ram Dayalu Singh Sustainable Development Foundation (RDSSDF) and the Amyloidosis Support Group of India (ASGI), he created India's first dedicated amyloidosis support network. Driven by lived experience, Dr. Chandra bridges awareness gaps, accelerates early diagnosis, advocates for affordable care, and empowers patients, caregivers, and clinicians across the country.
His leadership aligns ASGI with RDSSDF's broader mission of public health equity, rural outreach, and systemic change — inspiring a movement where no one faces amyloidosis alone.
A more refined, compact and premium presentation of ASGI’s awareness initiatives, healthcare collaborations and milestone achievements.
A major national symposium bringing together healthcare professionals, researchers, academicians and patient advocates to advance awareness, diagnosis, treatment and patient care for Amyloidosis in India.
Featured Milestone
Browse ASGI video highlights in a smooth auto-sliding showcase. Open any video for a larger popup player and continue through the full video set.
A snapshot of ASGI’s growing reach, community network and support ecosystem.
Clinical expertise, diagnostics and patient-focused leadership come together here to strengthen ASGI’s role in awareness, guidance and support for patients and families.
Patron – Amyloidosis Support Group of India (AIIMS)
Professor of Haematology at All India Institute of Medical Sciences (AIIMS), New Delhi. She leads the technical working group for haemophilia and haemoglobinopathies and is a member of the Hemophilia Federation India (HFI) Executive Committee and Founding Trustee of GAP Health.
View Profile
Vice Patron – Amyloidosis Support Group of India (Fortis)
Principal Director & Chief – Haematology, Haemato Oncology, BMT & CAR-T Cell Therapy at Fortis. He pioneered low-cost stem cell transplant centres across India and is committed to the vision of an anaemia-free and thalassemia-free India through government collaborations.
View Profile
Principal Advisor – Communication & External Relationships (Lal PathLabs)
Director of Renal Pathology, Electron Microscopy & Head of R&D at Dr. Lal PathLabs. A highly respected renal pathologist with deep expertise in amyloid typing and kidney biopsy diagnostics.
View ProfileASGI combines medical knowledge, diagnostic insight and compassionate guidance to support awareness, understanding and stronger patient care pathways.
Your support helps ASGI expand patient guidance, strengthen awareness, encourage earlier recognition and build a more connected support ecosystem for individuals and families affected by amyloidosis.
Instead of a typical donation block, this section highlights the real impact of support — from patient guidance to awareness-building and stronger community connection.
Help strengthen access to reliable information, community care and supportive guidance.
Contribute to public understanding, advocacy and conversations that encourage earlier diagnosis.
Help ASGI build a stronger support network across education, community and outreach.
Personal reflections from people living with amyloidosis — stories of uncertainty, resilience, hope and the strength of community support.
“If you need information, emotional support, or just a listening ear — our community is here for you.”
“Amyloidosis brought uncertainty, but with the right care, I remain hopeful for a better life.”
“Amyloidosis changed my life, but I stay resilient. I continue fighting with hope and support.”